Chimpanzees in hepatitis C virus research: 1998-2007

被引:18
作者
Bettauer, R. H. [1 ]
机构
[1] Bettauer BioMed Res, Mclean, VA USA
关键词
animal model; HCV; hepatitis; hepatitis C virus; Pan troglodytes; HYPERVARIABLE REGION 1; CELLULAR IMMUNE-RESPONSES; IN-VIVO; T-CELLS; NEUTRALIZING ANTIBODIES; INOCULATED CHIMPANZEES; RECOVERED CHIMPANZEES; INFECTED CHIMPANZEES; DENSITY-LIPOPROTEIN; NONHUMAN-PRIMATES;
D O I
10.1111/j.1600-0684.2009.00390.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background Chimpanzees have been widely used in hepatitis C virus (HCV) research, but their endangered status and high financial and ethical costs have prompted a closer review. Methods One hundred and nine articles published in 1998-2007 were analyzed for the number of chimpanzees involved, experimental procedures, objectives and other relevant issues. Results The articles described the use of 852 chimpanzees, but accounting for likely multiple uses, the number of individual chimpanzees involved here is estimated to be approximately 500. Most articles addressed immunology and inoculation studies. A significant portion of studies lasted for several months or years. Approximately one half of the individual chimpanzees were each used in 2-10 studies. Conclusions Significant financial and scientific resources have been expended in these chimpanzee HCV studies. Discussion addresses troublesome questions presented by some of the reviewed articles, including statistical validity, repeatability, and biological relevance of this model. These concerns merit attention as future approaches to HCV research and research priorities are considered.
引用
收藏
页码:9 / 23
页数:15
相关论文
共 101 条
[61]   Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees [J].
Nascimbeni, M ;
Mizukoshi, E ;
Bosmann, M ;
Major, ME ;
Mihalik, K ;
Rice, CM ;
Feinstone, SM ;
Rehermann, B .
JOURNAL OF VIROLOGY, 2003, 77 (08) :4781-4793
[62]  
*NAT CTR RES RES N, CHIMP MAN PROGR
[63]  
*NAT HUM GEN RES I, 1 MAJ RES ENCODE PRO
[64]  
*NAT I ALL INF DIS, 2005, VACC HEP C VIR
[65]  
*NAT SCI BOARD, 2002, PUBL ATT S T SCI RES
[66]  
*NIH, 2002, MAN HEP C 2000 CONS
[67]   Binding of hepatitis C virus to CD81 [J].
Pileri, P ;
Uematsu, Y ;
Campagnoli, S ;
Galli, G ;
Falugi, F ;
Petracca, R ;
Weiner, AJ ;
Houghton, M ;
Rosa, D ;
Grandi, G ;
Abrignani, S .
SCIENCE, 1998, 282 (5390) :938-941
[68]   Human occludin is a hepatitis C virus entry factor required for infection of mouse cells [J].
Ploss, Alexander ;
Evans, Matthew J. ;
Gaysinskaya, Valeriya A. ;
Panis, Maryline ;
You, Hana ;
de Jong, Ype P. ;
Rice, Charles M. .
NATURE, 2009, 457 (7231) :882-886
[69]   Significance of the anti-E2 response in self-limited and chronic hepatitis C virus infections in chimpanzees and in humans [J].
Prince, AM ;
Brotman, B ;
Lee, DH ;
Ren, L ;
Moore, BS ;
Scheffel, JW .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04) :987-991
[70]   Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model [J].
Prince, AM ;
Brotman, B ;
Lee, DH ;
Pfahler, W ;
Tricoche, N ;
Andrus, L ;
Shata, MT .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (10) :1701-1709